FI933391L - Triazolyltiometyltio-cefalosporin-hydroklorid, dess kristalliserad hydrat samt foerfarande foer deras framstaellning - Google Patents

Triazolyltiometyltio-cefalosporin-hydroklorid, dess kristalliserad hydrat samt foerfarande foer deras framstaellning Download PDF

Info

Publication number: FI933391L
Authority: FI; Finland
Prior art keywords: triazolylthiomethylthio; kristalserada; hydrat; dess; foerfarande foer
Prior art date: 1992-07-31

Application number

FI933391A

Other languages

English (en)

Other versions

FI933391A0 (fi

Inventor

Hisanori Takahashi

Yutaka Ide

Original Assignee

Shionogi & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-31

Filing date

1993-07-29

Publication date

1994-02-01

1993-07-29 Application filed by Shionogi & Co filed Critical Shionogi & Co

1993-07-29 Publication of FI933391A0 publication Critical patent/FI933391A0/fi

1994-02-01 Publication of FI933391L publication Critical patent/FI933391L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cephalosporin Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FI933391A 1992-07-31 1993-07-29 Triazolyltiometyltio-cefalosporin-hydroklorid, dess kristalliserad hydrat samt foerfarande foer deras framstaellning FI933391L (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP20496592		1992-07-31

Publications (2)

Publication Number	Publication Date
FI933391A0 FI933391A0 (fi)	1993-07-29
FI933391L true FI933391L (fi)	1994-02-01

Family

ID=16499234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI933391A FI933391L (fi)	1992-07-31	1993-07-29	Triazolyltiometyltio-cefalosporin-hydroklorid, dess kristalliserad hydrat samt foerfarande foer deras framstaellning

Country Status (23)

Country	Link
US (1)	US5407929A (fi)
EP (1)	EP0581552B1 (fi)
KR (1)	KR100245938B1 (fi)
CN (1)	CN1037683C (fi)
AT (1)	ATE165360T1 (fi)
AU (1)	AU657866B2 (fi)
BR (1)	BR9303235A (fi)
CA (1)	CA2101502A1 (fi)
DE (1)	DE69318077T2 (fi)
ES (1)	ES2115725T3 (fi)
FI (1)	FI933391L (fi)
GR (1)	GR3026699T3 (fi)
HU (1)	HU219637B (fi)
IL (1)	IL106516A (fi)
MX (1)	MX9304611A (fi)
NO (1)	NO303734B1 (fi)
NZ (1)	NZ248285A (fi)
PH (1)	PH30109A (fi)
PL (2)	PL172830B1 (fi)
RU (1)	RU2118959C1 (fi)
TW (1)	TW307769B (fi)
UA (1)	UA37181C2 (fi)
ZA (1)	ZA935529B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE430749T1 (de) *	2001-02-24	2009-05-15	Boehringer Ingelheim Pharma	Xanthinderivate verwendung als arzneimittel sowie deren verfahren zur deren herstellung
AT413282B (de) *	2002-02-01	2006-01-15	Sandoz Ag	Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
KR20030076759A (ko) *	2002-03-21	2003-09-29	주식회사 엘지생명과학	신규 세팔로스포린 화합물 및 그의 제조 방법
US7407955B2 (en) *	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US6727277B1 (en)	2002-11-12	2004-04-27	Kansas State University Research Foundation	Compounds affecting cholesterol absorption
CA2513837A1 (en)	2003-02-12	2004-08-26	Paul Adriaan Van Der Schaaf	Crystalline forms of pitavastatin calcium
ATE440101T1 (de)	2003-03-27	2009-09-15	Basilea Pharmaceutica Ag	Cephalosporin in kristalliner form
US7501426B2 (en) *	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de)	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20080251A1 (es) *	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
BRPI0711558A2 (pt) *	2006-05-04	2011-11-08	Boeringer Ingelheim Internat Gmbh	polimorfos
MX2010001821A (es) *	2007-08-17	2010-03-10	Boehringer Ingelheim Int	Derivados de purina para uso en el tratamiento de enfermedades relacionadas con fap.
PE20091730A1 (es)	2008-04-03	2009-12-10	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) *	2008-06-03	2010-02-23	Boehringer Ingelheim Int	Tratamiento de nafld
KR20190016601A (ko)	2008-08-06	2019-02-18	베링거 인겔하임 인터내셔날 게엠베하	메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
US20110190322A1 (en) *	2008-08-14	2011-08-04	Boehringer Ingelheim International Gmbh	Purin derivatives for use in the treatment of fab-related diseases
MX2011002558A (es)	2008-09-10	2011-04-26	Boehringer Ingelheim Int	Terapia de combinacion para el tratamiento de diabetes y estados relacionados.
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en)	2008-12-23	2015-09-03	Boehringer Ingelheim International Gmbh	Salt forms of organic compound
AR074990A1 (es)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
NZ599298A (en)	2009-11-27	2014-11-28	Boehringer Ingelheim Int	Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
MX366325B (es)	2010-05-05	2019-07-05	Boehringer Ingelheim Int	Terapia de combinacion.
EP3366304B1 (en)	2010-06-24	2020-05-13	Boehringer Ingelheim International GmbH	Diabetes therapy
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
PL3517539T3 (pl)	2011-07-15	2023-04-24	Boehringer Ingelheim International Gmbh	Podstawiona dimeryczna pochodna chinazoliny, sposób jej wytwarzania i jej zastosowanie w kompozycjach farmaceutycznych do leczenia cukrzycy typu I i II
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
US20130303462A1 (en)	2012-05-14	2013-11-14	Boehringer Ingelheim International Gmbh	Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2015128453A1 (en)	2014-02-28	2015-09-03	Boehringer Ingelheim International Gmbh	Medical use of a dpp-4 inhibitor
CN109310697A (zh)	2016-06-10	2019-02-05	勃林格殷格翰国际有限公司	利格列汀和二甲双胍的组合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE65926B1 (en) *	1990-07-19	1995-11-29	Shionogi & Co	Thioalkylthio cephalosporin derivatives

1993
- 1993-07-26 DE DE69318077T patent/DE69318077T2/de not_active Expired - Fee Related
- 1993-07-26 TW TW082105942A patent/TW307769B/zh active
- 1993-07-26 EP EP93305864A patent/EP0581552B1/en not_active Expired - Lifetime
- 1993-07-26 AT AT93305864T patent/ATE165360T1/de not_active IP Right Cessation
- 1993-07-26 ES ES93305864T patent/ES2115725T3/es not_active Expired - Lifetime
- 1993-07-27 US US08/097,205 patent/US5407929A/en not_active Expired - Fee Related
- 1993-07-27 UA UA93003172A patent/UA37181C2/uk unknown
- 1993-07-28 IL IL106516A patent/IL106516A/en not_active IP Right Cessation
- 1993-07-28 CA CA002101502A patent/CA2101502A1/en not_active Abandoned
- 1993-07-28 HU HU9302194A patent/HU219637B/hu not_active IP Right Cessation
- 1993-07-28 AU AU44227/93A patent/AU657866B2/en not_active Ceased
- 1993-07-29 PL PL93317972A patent/PL172830B1/pl unknown
- 1993-07-29 PL PL93299870A patent/PL172835B1/pl unknown
- 1993-07-29 PH PH46601A patent/PH30109A/en unknown
- 1993-07-29 NZ NZ24828593A patent/NZ248285A/en unknown
- 1993-07-29 FI FI933391A patent/FI933391L/fi unknown
- 1993-07-30 ZA ZA935529A patent/ZA935529B/xx unknown
- 1993-07-30 MX MX9304611A patent/MX9304611A/es unknown
- 1993-07-30 BR BR9303235A patent/BR9303235A/pt not_active Application Discontinuation
- 1993-07-30 RU RU93047027/04A patent/RU2118959C1/ru not_active IP Right Cessation
- 1993-07-30 NO NO932745A patent/NO303734B1/no unknown
- 1993-07-30 KR KR1019930014742A patent/KR100245938B1/ko not_active IP Right Cessation
- 1993-07-31 CN CN93117437A patent/CN1037683C/zh not_active Expired - Fee Related
1998
- 1998-04-23 GR GR980400753T patent/GR3026699T3/el unknown

Also Published As

Publication number	Publication date
TW307769B (fi)	1997-06-11
IL106516A (en)	1998-06-15
PL299870A1 (en)	1994-02-07
IL106516A0 (en)	1993-11-15
AU657866B2 (en)	1995-03-23
DE69318077D1 (de)	1998-05-28
ES2115725T3 (es)	1998-07-01
CA2101502A1 (en)	1994-02-01
EP0581552B1 (en)	1998-04-22
MX9304611A (es)	1994-02-28
PH30109A (en)	1996-12-27
HU219637B (hu)	2001-06-28
FI933391A0 (fi)	1993-07-29
HU9302194D0 (en)	1993-10-28
BR9303235A (pt)	1994-03-01
EP0581552A3 (en)	1994-06-01
RU2118959C1 (ru)	1998-09-20
UA37181C2 (uk)	2001-05-15
NO303734B1 (no)	1998-08-24
US5407929A (en)	1995-04-18
DE69318077T2 (de)	1998-10-29
NZ248285A (en)	1994-07-26
ATE165360T1 (de)	1998-05-15
NO932745L (no)	1994-02-01
ZA935529B (en)	1994-02-24
AU4422793A (en)	1994-02-03
HUT68602A (en)	1995-06-28
PL172830B1 (pl)	1997-12-31
KR940005636A (ko)	1994-03-22
GR3026699T3 (en)	1998-07-31
CN1037683C (zh)	1998-03-11
EP0581552A2 (en)	1994-02-02
NO932745D0 (no)	1993-07-30
CN1089948A (zh)	1994-07-27
KR100245938B1 (ko)	2000-04-01
PL172835B1 (pl)	1997-12-31

Publication	Publication Date	Title
FI933391L (fi)	1994-02-01	Triazolyltiometyltio-cefalosporin-hydroklorid, dess kristalliserad hydrat samt foerfarande foer deras framstaellning
FI924963L (fi)	1993-05-08	Staerkelsefibrer, foerfarande foer deras framstaellning samt deras anvaendning
DK0686336T3 (da)	1999-01-18	Hændelseskorrelation
FI922601L (fi)	1992-12-22	Haollfast dekorationslaminat med utomordentligt utseende och rengoerbarhet, samt foerfarande foer dess tillverkning
FI925126A0 (fi)	1992-11-11	Luftsepareringscykel, som omfattar flerstegsfoervaermare och dubbelkolonn, fungerande under kompression och hoegt tryck samt dess integration med gasturbiner
DE59304485D1 (de)	1996-12-19	Einteiliges Halteelement
FI924141A (fi)	1993-03-18	Optisk kommutator samt dess tilverkningsfoerfarande
FI930930A0 (fi)	1993-03-03	Cellulosaprodukt som innehaoller en olefinoxidpolymer samt foerfarande foer dess framstaellning
FI931414L (fi)	1993-10-02	Imidazolderivat, foerfarande foer deras framstaellning samt deras anvaendning i terapi
FI932868L (fi)	1993-12-23	2'-deoxi-2'2'-difluor(2,6,8-substituerade) purinnukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter
DK0723738T3 (da)	1998-10-19	Magasinarrangement
FI933980A0 (fi)	1993-09-10	Skyddsplagg foer hygienkraevande objekt, saosom operationssalar
FI934313L (fi)	1994-04-06	Foerfarande foer framstaellning av fiberfoerstaerkt, termoplastiskt aemne samt anordning foer dess genomfoerande
FI934875A0 (fi)	1993-11-04	Foerfarande foer att saenda radiosignaler samt en TDMA-saendarmottagare
FI933408L (fi)	1993-07-30	Ksylanas, ksylanas producerande bacillus-stammar samt deras utnyttjande
FI935478A0 (fi)	1993-12-07	Sollins och dess baerare och framstaellningsfoerfarande samt anordning foer producering och ackumulering av vaete, elektricitet, aonga och vaerme daermed samt pumpning av vaetska
FI921247L (fi)	1992-03-23	Vattenhaltig lackspray-skydds- belaeggning foer spraykammare samt foerfarande foer dess tillverkning.
FI924791L (fi)	1993-04-24	Xantatdisulfidgrupper innehaollande polymerer, foerfarande foer deras framstaellning samt deras anvaendning
FI923229L (fi)	1993-01-16	Isolerad takplatta samt foerfarande foer dess framstaellning
FI930983L (fi)	1993-03-05	Raelsfordonhjul, foerfarande foer dess saeghaerdning samt anordning foer genomfoerande av foerfarandet
DE59410412D1 (de)	2005-09-22	Bislactone
FI930287A0 (fi)	1993-01-25	Plastroer eller -profil med flera avdelningar, foerfarande foer dess framstaellning samt foerbindningsstycke
FI894589A0 (fi)	1989-09-28	Underlagsmaterial foer parkettgolv samt foerfarande foer dess framstaellning.
FI930961A0 (fi)	1993-03-04	Matstation foer koettboskap, saerskilt svin
FI954385A0 (fi)	1995-09-18	Loedpasta, dess anvaendning samt loedfoerfarande